IL125225A - Fsh and lh separation and purification process - Google Patents
Fsh and lh separation and purification processInfo
- Publication number
- IL125225A IL125225A IL12522597A IL12522597A IL125225A IL 125225 A IL125225 A IL 125225A IL 12522597 A IL12522597 A IL 12522597A IL 12522597 A IL12522597 A IL 12522597A IL 125225 A IL125225 A IL 125225A
- Authority
- IL
- Israel
- Prior art keywords
- fsh
- process according
- chromatography column
- water solution
- buffer
- Prior art date
Links
- 238000000746 purification Methods 0.000 title claims abstract description 23
- 238000000926 separation method Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 36
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 36
- 239000011347 resin Substances 0.000 claims abstract description 27
- 229920005989 resin Polymers 0.000 claims abstract description 27
- 238000011068 loading method Methods 0.000 claims abstract description 16
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004255 ion exchange chromatography Methods 0.000 claims abstract description 13
- 125000000129 anionic group Chemical group 0.000 claims abstract description 11
- 238000001042 affinity chromatography Methods 0.000 claims abstract description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 8
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 8
- 230000003612 virological effect Effects 0.000 claims abstract description 7
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003446 ligand Substances 0.000 claims abstract description 4
- 239000011780 sodium chloride Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 49
- 239000000872 buffer Substances 0.000 claims description 17
- 229920000936 Agarose Polymers 0.000 claims description 11
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 11
- 239000007986 glycine-NaOH buffer Substances 0.000 claims description 10
- 239000001488 sodium phosphate Substances 0.000 claims description 8
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 8
- 230000001143 conditioned effect Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 3
- 239000008351 acetate buffer Substances 0.000 claims description 2
- YKCWQPZFAFZLBI-UHFFFAOYSA-N cibacron blue Chemical group C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=C1S(O)(=O)=O)=CC=C1NC(N=1)=NC(Cl)=NC=1NC1=CC=CC=C1S(O)(=O)=O YKCWQPZFAFZLBI-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 abstract 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 79
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 79
- 229940028334 follicle stimulating hormone Drugs 0.000 description 79
- 108010073521 Luteinizing Hormone Proteins 0.000 description 63
- 102000009151 Luteinizing Hormone Human genes 0.000 description 63
- 229940040129 luteinizing hormone Drugs 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 230000000694 effects Effects 0.000 description 21
- 229940088597 hormone Drugs 0.000 description 17
- 239000005556 hormone Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 108010057021 Menotropins Proteins 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000010828 elution Methods 0.000 description 11
- 238000004587 chromatography analysis Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000007974 sodium acetate buffer Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- 238000011109 contamination Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 3
- 239000001639 calcium acetate Substances 0.000 description 3
- 235000011092 calcium acetate Nutrition 0.000 description 3
- 229960005147 calcium acetate Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000003635 pituitary gland Anatomy 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000000035 BCA protein assay Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000011082 depyrogenation Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Amplifiers (AREA)
- Compounds Of Unknown Constitution (AREA)
- Executing Machine-Instructions (AREA)
- External Artificial Organs (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI002313A IT1287138B1 (it) | 1996-11-07 | 1996-11-07 | Procedimento per la separazione e purificazione di fsh e lh |
| PCT/EP1997/006058 WO1998020039A1 (en) | 1996-11-07 | 1997-11-03 | Fsh and lh separation and purification process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL125225A0 IL125225A0 (en) | 1999-03-12 |
| IL125225A true IL125225A (en) | 2002-04-21 |
Family
ID=11375168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12522597A IL125225A (en) | 1996-11-07 | 1997-11-03 | Fsh and lh separation and purification process |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0882064B1 (it) |
| AT (1) | ATE236931T1 (it) |
| AU (1) | AU719560B2 (it) |
| CA (1) | CA2242325C (it) |
| DE (1) | DE69720693T2 (it) |
| ES (1) | ES2196380T3 (it) |
| IL (1) | IL125225A (it) |
| IT (1) | IT1287138B1 (it) |
| PT (1) | PT882064E (it) |
| WO (1) | WO1998020039A1 (it) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6414123B1 (en) * | 1997-10-21 | 2002-07-02 | Vitro Diagnostics, Inc. | Method for purifying FSH |
| JP4574865B2 (ja) * | 1999-04-16 | 2010-11-04 | インスチチュート マッソーネ エス．エイ． | 高度に精製されたゴナドトロピン組成物およびそれらの製造方法 |
| US7022822B1 (en) * | 1999-04-16 | 2006-04-04 | Instituto Massone S.A. | Highly purified gonadotropin compositions and process for preparing them |
| EA006605B1 (ru) * | 2000-02-22 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО чХГ |
| EA004385B1 (ru) * | 2000-02-22 | 2004-04-29 | Апплайд Резеч Системз Арс Холдинг Н.В. | Способ выделения лютеинизирующего гормона |
| EP1809663B1 (en) | 2004-11-09 | 2008-09-17 | Ares Trading S.A. | Method for purifying fsh |
| RS57549B1 (sr) | 2005-08-26 | 2018-10-31 | Ares Trading Sa | Proces za pripremu glikoziliranog interferona beta |
| CA2625978A1 (en) * | 2005-12-09 | 2007-06-14 | Ares Trading S.A. | Method for purifying fsh or a fsh mutant |
| CN101397339B (zh) * | 2008-09-24 | 2012-07-25 | 上海天伟生物制药有限公司 | 糖蛋白中去除/灭活病毒的方法 |
| EP2325194A1 (en) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
| CN101792482B (zh) * | 2010-03-12 | 2012-11-21 | 丽珠医药集团股份有限公司 | 一种促性腺激素的纯化方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58157720A (ja) * | 1982-03-15 | 1983-09-19 | Nippon Chem Res Kk | 高純度の胎盤性性腺刺戟ホルモンの製造法 |
-
1996
- 1996-11-07 IT IT96MI002313A patent/IT1287138B1/it active IP Right Grant
-
1997
- 1997-11-03 DE DE69720693T patent/DE69720693T2/de not_active Expired - Lifetime
- 1997-11-03 PT PT97950077T patent/PT882064E/pt unknown
- 1997-11-03 AT AT97950077T patent/ATE236931T1/de active
- 1997-11-03 WO PCT/EP1997/006058 patent/WO1998020039A1/en active IP Right Grant
- 1997-11-03 ES ES97950077T patent/ES2196380T3/es not_active Expired - Lifetime
- 1997-11-03 IL IL12522597A patent/IL125225A/en not_active IP Right Cessation
- 1997-11-03 EP EP97950077A patent/EP0882064B1/en not_active Expired - Lifetime
- 1997-11-03 CA CA002242325A patent/CA2242325C/en not_active Expired - Fee Related
- 1997-11-03 AU AU53162/98A patent/AU719560B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998020039A1 (en) | 1998-05-14 |
| AU5316298A (en) | 1998-05-29 |
| ATE236931T1 (de) | 2003-04-15 |
| EP0882064A1 (en) | 1998-12-09 |
| IT1287138B1 (it) | 1998-08-04 |
| IL125225A0 (en) | 1999-03-12 |
| ITMI962313A1 (it) | 1998-05-07 |
| DE69720693D1 (de) | 2003-05-15 |
| ES2196380T3 (es) | 2003-12-16 |
| DE69720693T2 (de) | 2004-03-04 |
| CA2242325A1 (en) | 1998-05-14 |
| CA2242325C (en) | 2008-04-29 |
| ITMI962313A0 (it) | 1996-11-07 |
| PT882064E (pt) | 2003-08-29 |
| EP0882064B1 (en) | 2003-04-09 |
| AU719560B2 (en) | 2000-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rosner et al. | Isolation and characterization of the testosterone-estradiol-binding globulin from human plasma. Use of a novel affinity column | |
| Boyd | A protein-bound form of porcine renal renin | |
| Cuatrecasas | Isolation of the insulin receptor of liver and fat-cell membranes | |
| Cuatrecasas | Affinity chromatography and purification of the insulin receptor of liver cell membranes | |
| EP0882064B1 (en) | Fsh and lh separation and purification process | |
| THORLEY‐LAWSON et al. | Separation and characterisation of tryptic fragments from the adenosine triphosphatase of sarcoplasmic reticulum | |
| US4022758A (en) | Isolation of coagulation factors I and VIII from biological material | |
| JPS59106428A (ja) | 精製された生物学的に活性なモノマ−状インタ−フエロンの製造方法 | |
| Eylar et al. | Allergic encephalomyelitis: Cleavage of the C-tryptophyl bond in the encephalitogenic basic protein from bovine myelin | |
| US6162905A (en) | FSH and LH separation and purification process | |
| O'Riordan et al. | Isolation and chemical properties of porcine parathyroid hormone | |
| Reichert Jr | [30] Purification of anterior pituitary hormones (ovine, bovine, rat, rabbit) | |
| Tindall et al. | Further studies on the accumulation and binding of androgen in rat epididymis | |
| Pottinger | Estrogen-binding sites in the liver of sexually mature male and female brown trout, Salmo trutta L | |
| IE47092B1 (en) | New glycoprotein and process for isolating it | |
| Mesiano et al. | Failure of acid–ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors | |
| CA1154438A (en) | Protein pp in15 xx, a process for its preparation and its use | |
| Free et al. | Separation and properties of multiple components of bovine growth hormone | |
| Cuatrecasas et al. | [85] Insulin receptors | |
| US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| JP2001323000A (ja) | Ｆｓｈ（卵胞刺激ホルモン）とｌｈ（黄体化ホルモン）の分離と精製工程 | |
| Movat et al. | A small molecular weight permeability factor in guinea pig serum: adsorption to antigen-antibody aggregates | |
| Esch et al. | [5] Microisolation of neuropeptides | |
| US3310471A (en) | Placental lactogenic factor process | |
| Sairam et al. | Binding of an inhibin-like protein from bull seminal plasma to ovine pituitary membranes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |